Back to BlackRock, Inc. BlackRock, Inc.

GTBPGTBP
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in GT BIOPHARMA INC

BlackRock, Inc. holds 8,312 shares of GTBP (GT BIOPHARMA INC), worth $4,070 as of 2026-Q2. The position was decreased (-1.1% shares).

Current Value

$4,070

Current Shares

8,312

Total Value Change

-$25,628

Total Shares Change

-1,425

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8,312
-1.1%
$4,0700.0%$0.49
0
2026-Q1
Decreased
8,408
-0.0%
$3,4310.0%$0.47
0
2025-Q4
Decreased
8,409
-13.6%
$6,6030.0%$0.81
0
2025-Q3
Unchanged
9,737
0.0%
$5,7110.0%$0.58
0
2025-Q2
Unchanged
9,737
0.0%
$34,8580.0%$3.54
0
2025-Q1
Unchanged
9,737
0.0%
$20,9350.0%$2.40
0
2024-Q4
New
9,737
-
$29,6980.0%$3.05
30

Other major holders of GTBP: BANK OF MONTREAL /CAN/, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used